CIK 0001420565
- Non-accelerated filer
- Smaller reporting company
Rein Therapeutics, Inc.
Sign in to watch- Ticker
- RNTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 134196017
- Phone
- +1 737-802-1989
- Business address
- 12407 N. MOPAC EXPY., SUITE 250 #390, AUSTIN, TX, 78758
- Former names
- Aileron Therapeutics, Inc., AILERON THERAPEUTICS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2017-07-05 | Gallagher Brian M. Jr. Director | Conversion · Series F Preferred Stock | −1,979,188 | 0 | ||
| 2017-07-05 | Sigma Emerging Markets Ltd. 10% owner | Conversion | +233,086 | 233,086 | ||
| 2017-07-05 | Sigma Emerging Markets Ltd. 10% owner | Purchase | +190,000 | $15.00 | $2.9M | 423,086 |
| 2017-07-05 | Sigma Emerging Markets Ltd. 10% owner | Conversion · Series F Preferred Stock | −2,316,176 | 0 | ||
| 2017-07-05 | EXCEL MEDICAL FUND LP 10% owner | Conversion | +956,100 | 956,100 | ||
| 2017-07-05 | EXCEL MEDICAL FUND LP 10% owner | Purchase | +60,000 | $15.00 | $900K | 1,016,100 |
| 2017-07-05 | EXCEL MEDICAL FUND LP 10% owner | Conversion · Series D Preferred Stock | −5,934,050 | 0 | ||
| 2017-07-05 | EXCEL MEDICAL FUND LP 10% owner | Conversion · Series E-2 Preferred Stock | −1,329,993 | 0 | ||
| 2017-07-05 | EXCEL MEDICAL FUND LP 10% owner | Conversion · Series E-3 Preferred Stock | −1,153,606 | 0 | ||
| 2017-07-05 | EXCEL MEDICAL FUND LP 10% owner | Conversion · Series F Preferred Stock | −1,083,119 | 0 | ||
| 2017-07-05 | Satter Muneer A 10% owner | Conversion | +144,773 | 144,773 | ||
| 2017-07-05 | Satter Muneer A 10% owner | Purchase | +33,333 | $15.00 | $500K | 178,106 |
| 2017-07-05 | Satter Muneer A 10% owner | Conversion · Series D Preferred Stock | −847,721 | 0 | ||
| 2017-07-05 | Satter Muneer A 10% owner | Conversion · Series E-2 Preferred Stock | −183,944 | 0 | ||
| 2017-07-05 | Satter Muneer A 10% owner | Conversion · Series E-3 Preferred Stock | −159,548 | 0 | ||
| 2017-07-05 | Satter Muneer A 10% owner | Conversion · Series F Preferred Stock | −247,398 | 0 | ||
| 2017-07-05 | KCK LTD. 10% owner | Conversion | +446,817 | 446,817 | ||
| 2017-07-05 | KCK LTD. 10% owner | Purchase | +200,000 | $15.00 | $3.0M | 646,817 |
| 2017-07-05 | KCK LTD. 10% owner | Conversion · Series E-3 Preferred Stock | −3,676,471 | 0 | ||
| 2017-07-05 | KCK LTD. 10% owner | Conversion · Series F Preferred Stock | −763,552 | 0 |
Page 14 of 16 · 320 trades